Moderna Has Big AI News. Is the Stock a Buy?
After two years in the doldrums, the stock is soaring. Moderna (MRNA 1.90%) isn't new to artificial intelligence (AI). The biotech best known for its billion-dollar coronavirus vaccine has been using this hot technology for years to help it save crucial time in the laboratory. For example, Moderna uses AI to produce mRNAs for researchers to work with, so they no longer have to create mRNA manually to run experiments. And last year, it signed a deal with International Business Machines to use its AI and quan ...